FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 104 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,317,680 | +18.0% | 522,000 | -12.3% | 0.01% | +20.0% |
| Q2 2023 | $1,964,490 | +162.5% | 595,300 | +126.7% | 0.01% | +150.0% |
| Q1 2023 | $748,410 | +60.6% | 262,600 | +310.3% | 0.00% | +100.0% |
| Q4 2022 | $465,920 | +14.5% | 64,000 | +27.2% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | -25.3% | 50,300 | -54.8% | 0.00% | -50.0% |
| Q2 2022 | $545,000 | -73.0% | 111,300 | +30.2% | 0.00% | -60.0% |
| Q1 2022 | $2,022,000 | -69.8% | 85,500 | -77.4% | 0.01% | -70.6% |
| Q4 2021 | $6,706,000 | +67.2% | 379,100 | +166.6% | 0.02% | +70.0% |
| Q3 2021 | $4,011,000 | – | 142,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |